Back to mobile site

H.C. Wainwright Reiterates Buy Rating on IN8bio Inc. (INAB)

November 26, 2024 7:05 AM EST Send to a Friend
H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $8.00 price target on IN8bio Inc. (NASDAQ: INAB).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login